(Riya Saha, Intern Journalist)India has formed an expert committee constituting of representatives from all relevant ministries and institutions to oversee all aspects of its Covid-19 vaccine plan, from the identification of the vaccine to buying to financing the purchase to distribution and administration — a move that comes even as six vaccines are in Phase 3 or combined Phase 2-3 trials and as countries around the world scramble to strike deals with multiple vaccine makers.
According to people familiar with the matter under the condition of anonymity said, the panel will be led by Niti Aayog’s Dr. VK Paul and co-chaired by health secretary Rajesh Bhushan. It will pick the vaccine or vaccines that India can use, plan the finances for what is sure to be an expensive purchase running into billions of dollars, and prioritize the sequence of administration.
About Post Author
